Pulmonary Tuberculosis

Pulmonary Tuberculosis Map

Get Started. It's Free
or sign up with your email address
Pulmonary Tuberculosis by Mind Map: Pulmonary Tuberculosis

1. Latent TB infection

2. - Infectious disease that mainly affects the lungs, can affect kidney, spine and brain.

3. - Caused by Mycobacterium Tuberculosis - Spread thru droplet transmission

4. - US: 2018 2.8 per 100,000 persons or 28 cases/million, 2025 Target ≤1.3 TB cases per 100,000 - PH: 2018 107M population 591K best est; uncertain interval 332–924K

5. - Preventable and curable - 1.5M dies every year

6. TB disease

7. - Symptoms:

7.1. cough 2 weeks or longer

7.2. chest pain

7.3. coughing up blood

7.4. weakness/fatigue

7.5. weight loss

7.6. loss of appetite

7.7. chills

7.8. fever

7.9. night sweats

8. - Risk Factors:

8.1. Contact with person with TB disease

8.2. Countries with high prevalance

8.3. High risk settings

8.4. Healthcare workers

8.5. Infants, children, and adolescents

9. - Vaccines: Bacille Calmette-Guerin (BCG)

10. - Testing:

10.1. TB Skin test - Mantoux tuberculin skin test

10.2. - Sputum Culture 3x

10.3. - QuantiFERON®-TB Gold In-Tube test (QFT-GIT)

10.4. - T-SPOT®.TB test (T-Spot)

10.5. - GeneXpert MTB/RI

11. - Assessment:

11.1. Symptoms of active TB

11.2. Vaccine

11.3. Chest X-ray

11.4. Lab tests

11.5. Site of disease

11.6. HIV risk assessment

11.7. History of TB disease

11.8. History of LTBI

11.9. History of other respiratory illness treatment

11.10. Underlying illness that increases risk for TB

11.11. Started treatment

11.12. Non-TB Meds

12. - Treatment

12.1. - Anti TB Drugs o isoniazid (INH). – prevent TB disease for LTBI o rifampin (RIF). o ethambutol (EMB). o pyrazinamide (PZA). o Streptomycin (STR).

12.2. - Anti bacterial drugs

12.3. - Special dietary meals

12.4. - Vitamins

12.5. - Probiotics

12.6. - Immunomodulators - HUMIRA

12.7. - Immunostimulants – Vaccines, drugs for chronic infections, immunodeficiency, autoimmunity and neoplastic disease. – TABRECTA – lung Ca